NL-OMON33641已完成不适用
Dopaminergic neurotransmission and cognitive deterioration in velocardiofacial syndrome - Dementia in VCFS
Medisch Universitair Ziekenhuis Maastricht0 个研究点目标入组 44 人开始时间: 待定最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 44
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Deletion 22q11.2
- •Group 1: premorbid IQ > 70 . At this moment IQ < 55
- •Group 2: premorbid IQ < 55
排除标准
- •Age < 18 and > 65
- •Somatic problems which mimic dementia, such as hypothroid.
- •Psychiatric disorders with dementia like symptoms, such as depressive disorder and dementia's of other origine
研究者
相似试验
进行中（未招募）
不适用
Dopaminergic neurotransmission and cognitive decline in velocardiofacial syndrome - Dementia in VCFSDementia in velocardiofacial syndromeMedDRA version: 8.1Level: LLTClassification code 10012267Term: DementiaEUCTR2006-006203-36-NLAcademic Medical Centre (AMC)
撤回
不适用
Dopaminergic neurotransmission and cognitive decline in velocardiofacial syndromedementiacognitive decline10083624NL-OMON31666Academisch Medisch Centrum40
尚未招募
不适用
Het dopamine systeem en cognitieve achteruitgang bij patiënten met VCFS.velocardiofacial syndromedel22q11.2dementiadementievelocardiofaciaal syndroomNL-OMON26307Governor Kremers Centre / Department of Clinical GeneticsMaastricht, the Netherlands44
招募中
不适用
Dopaminergic modulation of cognition and psychomotor functiogeen aandoeningNL-OMON38372niversiteit Maastricht30
已完成
不适用
Dopaminergic and noradrenergic brain mechanisms underlying attention, cognitive performance and reward learning.Psychiatric illnessADHDcognitive abilitiesattentionexecutive functionsreward learningschizophreniadepressionNL-OMON24350Maastricht University20